Aidoc, a maker of AI-based software that helps radiologists read medical scans and warn them of stroke or pulmonary embolism, has secured a $110 million Series D investment round to expand its technology development, sales and market reach. expand. said last week.
The new investment comes a year after Aidoc raised $66 million in a round led by US VC firm General Catalyst and announced new partnerships in the US to offer its AI capabilities to its radiologists. The round brings Aidoc’s total capital to $250 million so far.
Founded in 2016, Aidoc develops medical imaging software designed to detect and detect critical abnormalities for radiologists using deep learning and AI algorithms. The medical scans are quickly analyzed to help doctors triage patients and prioritize care.
Aidoc’s Series D investment announced Thursday was co-led by TCV Ventures, a California-based company that has backed companies like Airbnb, GoDaddy and Spotify, and Alpha Intelligence Capital (AIC), a private venture fund specializing in AI and machine learning startups, with the participation of CDIB Capital, a Hong Kong-based company that operates as the overseas investment arm of China Development Financial, headquartered in Taiwan.
Aidoc said the new investment will drive the continued expansion of the company’s AI platform, which “enables hospitals to address their most prominent challenges, especially in the post-pandemic realities of doctor and nurse shortages, rising delivery costs and a increasingly challenging economic environment. †
“We are building the kind of breadth and depth in AI that will enable hospitals to fundamentally change the way they do business and provide the solutions needed to compete successfully in these challenging times,” said Aidoc CEO Elad Walach in a statement. declaration.
Aidoc employees in Tel Aviv. (Guy Shriber)
“Aidoc is already the leading AI platform for imaging, but with this new investment round, our goal is to massively expand our AI healthcare platform to cover both hospitals’ various medical service lines and deep integration into clinical workflows, enabling hospitals to activate specialist care teams and deliver the best quality of care to patients in a scalable, efficient way,” said Walach.
The healthcare platform includes 15 FDA-approved clinical solutions for conditions such as stroke, vertebral fracture, pulmonary embolism (PE), and cerebral haemorrhage, and activates alerts to support medical professionals in their decision-making process and to reduce turnaround time.
“Through the platform, clinicians can spend more time engaging patients, being proactive and providing higher quality treatment, rather than being swallowed up by manual processes, being responsive to incoming requests, and risking patients being misled by the gaps are slipping,” the company said.
Israel’s Six Largest Medical Centers Started using Aidoc’s technology end of 2020. These are Hadassah Medical Center in Jerusalem, Sourasky Medical Center (Ichilov) in Tel Aviv, Rabin Medical Center (Beilinson and Hasharon Hospitals) in Petah Tikva, Assuta Medical Centers, Shaare Zedek and Haim Sheba Medical Center in Tel Hashomer, which the first hospital was to implement the company’s solutions in Israel.
